Sonalasense Achieves Significant Clinical, Growth And Funding Milestones Toward Its Mission To Soundly Defeat Cancer
Round Type
Funding Round
BerkeleyBiotechnologySoftwareDescription
SonALAsense, a pioneer in the development of SONALA-001 and sonodynamic therapy (SDT), a new drug-device combination developed to manage deadly cancers so patients can become survivors, today announced clinical, organizational and growth updates. It is the only company with SDT in clinical trials.
Who else raised in Biotechnology and Software around the same time
Companies in the same sectors as SonALAsense that raised within 45 days of this round, from Fundz verified event records.
- FundamentalVR raised $20M (Funding Round) on August 11, 2022.
- Biofourmis raised an undisclosed amount (Series D) on August 10, 2022.
- Sympatic raised an undisclosed amount (Pre-Seed) on August 4, 2022.
- Medical Microinstruments raised $75M (Funding Round) on July 20, 2022.
- PMGC Holdings Inc. raised $2.1M (Seed) on July 15, 2022.
- Nucleus Genomics raised $18M (Funding Round) on July 14, 2022.
Who to call at SonALAsense, and when
A new round usually means SonALAsense is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SonALAsense raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SonALAsense, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SonALAsense. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SonALAsense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SonALAsense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.